|
Expert Updates in COVID19: An Animated Video Series
Five animated videos clearly explain managing patients with COVID19, lung disease, ARDS, or long-COVID. Hear from the leading pulmonologists on best practices based on the latest literature. |
|
|
TEAM UP: Defining and Refining Optimal HIV Care During the COVID-19 Pandemic
In this webcast series, members of the DAP Health team review key data and discuss their real-world experiences providing care for persons living with HIV during the COVID-19 pandemic. DAP Health opened one of California’s first COVID-19 clinics and hotlines to offer screening, testing, and treatment.
Topics covered in this webcast series include:
COVID-19–Related Complications in Persons Living With HIV (PLWH);
COVID-19 Testing Strategies;
Home Care for PLWH Diagnosed With COVID-1... |
|
Understanding Evolving Therapeutic Strategies for Graft-Versus-Host Disease (Module 1: Diagnosis, Risk Assessment, and Staging; Module 2: Current and Emerging Therapeutic Strategies)
STATEMENT OF NEED
Graft-versus-host disease (GVHD) is a major complication of allogeneic hematopoietic stem cell transplant (HSCT), affecting between 40% and 60% of patients and accounting for 15% of posttransplant mortality. Acute GVHD is the second-leading cause of transplant-related mortality and typically targets the skin, gastrointestinal tract, and liver. Chronic GVHD often presents during the first year following HSCT but may develop in subsequent years and most commonly affects the ... |
|
Diagnosis, Treatment and Prevention Therapies in Primary Headache Disorders
ACTIVITY OVERVIEW
Primary headache disorders are a major cause of disability and a common reason people seek medical care. However, distinguishing a primary from a secondary headache disorder, as well as among primary headache disorders, is often challenging. Focusing on cluster and migraine, Drs. Jessica Ailani and Stewart Tepper provide criteria and strategies to overcome this challenge in the office setting. Insight is also provided to help guide treatment with evidence-based medications a... |
|
Preceptor Mini-Series 6: The Reason I Jump - An Interprofessional Mini-Series
(See movie trailer below detailed description).
This is a 12 episode, knowledge-based, video series developed to educate both preceptors and students regarding their participation in experiential rotations in an Interprofessional setting. Each individual video episode is 8 - 14 minutes in length and builds upon the next. The series follows multiple health professional preceptors including nurses, pharmacists, physicians, speech-language-pathologists, occupational therapists, athlethic tr... |
|
|
Preceptor Mini-Series 5: Change of Heart - An Interprofessional Mini-Series
(See movie trailer below detailed description).
This is a 12 episode, knowledge-based, video series developed to educate both preceptors and students regarding their participation in experiential rotations in an Interprofessional setting. Each individual video episode is 5-10 minutes in length and builds upon the next. The series follows multiple health professional preceptors including nurses, pharmacists, physicians, speech-language-pathologists, occupational therapists, and physical t... |
|
|
Preceptor Mini-Series 4: A Glimpse Into the Life of a Community Pharmacy Preceptor
(See movie trailer below detailed description).
This 6-episode Series follows a pharmacy student and preceptor from orientation to the midpoint of a community rotation. Each video episode is 5-8 minutes in length and builds upon the next. During the Series you will experience a combination of inappropriate and quality interactions between the student, the preceptor, patients, and technicians. At moments throughout each episode, two preceptor experts provide humorous interactions and sha... |
|
|
Preceptor Mini-Series 3: Residency Preceptor's Experience
(See movie trailer below detailed description).
This 6-episode Series follows a pharmacy resident and preceptor during a clinical rotation at a hospital. Each video episode is 5-8 minutes in length and builds upon the next. During the Series you will view interactions between the resident, preceptor, residency director, and health-care team as they progress through the clinical rotation. At moments throughout each episode, two preceptor experts provide humorous interactions and share ... |
|
|
Preceptor Mini-Series 2: Adventures of Interprofessional Precepting
(See movie trailer below detailed description).
This is a 12 episode, knowledge-based, video series developed to provide educational pearls to preceptors who train students or residents on experiential rotations in an Interprofessional setting.
Each video episode is 5-8 minutes in length and builds upon the next. The series follows three health professional preceptors including a nurse, pharmacist, and physician as they precept their students in an ambulatory care setting. Through a... |
|
|
Preceptor Mini-Series 1: Preceptor Pharm Tools
(See movie trailer below detailed description).
This is a 12 episode, knowledge-based, video series developed to provide educational pearls to preceptors who train pharmacy students or residents on experiential rotations. Each video episode is 5-8 minutes in length and builds upon the next. The series follows a young preceptor and two students through a 6 week clinical rotation at a hospital. The two students are polar opposites and present unique challenges to the preceptor. At moments ... |
|
|
@MondayNightIBD OnDemand: Addressing the Cases That Challenge Your Practice
Statement of Need
Gastroenterologists are trailblazers in health care social media, and #MondayNightIBD (#MNIBD) has harnessed that energy to establish gastroenterologists as not just social media influencers but as clinical practice influencers as well. #MNIBD is not just a weekly social media conversation - it is an international platform that is moving the field forward by crowdsourcing the expertise of leading inflammatory bowel disease (IBD) experts, community clinicians, and patients ... |
|
|
At-Risk Patients Hidden in Plain Sight: Real-World Strategies for Screening and Treating Hepatitis B Virus
Statement of Need
Chronic hepatitis B virus (HBV) remains a global epidemic, resulting in significant morbidity and mortality. In 2015, there were 257 million people worldwide infected with HBV. In 2016, only 10.5% were diagnosed, with only 16.7% receiving treatment, and without intervention, there are 19 million deaths anticipated by the end of 2020. These numbers are startling as they exist despite the availability of effective treatment, and this is in part due to lack of clinician knowl... |
|
|
Pharmacy Technician Series: Cultural Competency With Transgender Patients
See webpage |
|
|
A One-Dose Wonder for Influenza Post-Exposure Prophylaxis
2020 was the year of COVID-19. Now it's time to focus back on influenza. Baloxavir received an indication for post-exposure prophylaxis for individuals with recent contact of the influenza virus based on the trial from Ikematsu et al. Join us to learn if baloxavir can not just treat influenza but prevent infections. |
|
|
Facts on COVID-19 Vaccinations: Pfizer BioNTech
Pharmacists and other health professionals can play crucial roles in administering and advocating for vaccination, especially during the pandemic. Learners’ knowledge should stay up-to-date in order to serve the population and aid in efforts to gaining herd immunity with vaccinations. |
|
|
Veterinary Pharmacy Conference 2021
June 11-12, 2021
Join ACVP at the Annual Veterinary Pharmacy Conference— in response to the COVID-19 pandemic, ACVP has decided to bring you our Veterinary Pharmacy Conference virtually this summer.
All you need to do is register, login, and get ready to connect and learn.
The ACVP Veterinary Pharmacy Virtual Conference is the only national conference designed exclusively for community veterinary pharmacy. Ideal for both new and established veterinary pharmacy practices, this confe... |
|
|
Sparing and Restoring the Gut Microbiota: Clinical Case Challenges: Treatment of C. difficile Infection
Dr. Sahil Khanna and Dr. Kevin Garey use a case-based approach to walk participants through the selection of therapy for two patients with C. difficile infection. Discussion topics include risk factors, triaging severity of infection, and guideline-recommended therapies. Clinical decision points throughout the activity allow learners to test their skills in managing patients with C. difficile, identify risk factors, and treat with available antimicrobial therapies. |
|
|
Safety and Efficacy of Emerging Treatments in the Management of Systemic Lupus Erythematosus (SLE)
When measuring outcomes in systemic lupus erythematosus (SLE), it is important for clinicians to monitor disease activity, health-related quality of life, and any irreversible change in the organ system that occurred since the onset of SLE. While there are currently many therapies utilized in treating SLE, such as nonsteroidal anti-inflammatory drugs (NSAIDs), steroids, antimalarials, immunosuppressants, chemotherapy, biologics, and adjunctive therapies, there are still unmet needs with a mort... |
|
|
Immune Pathways in Systemic Lupus Erythematosus (SLE)
Lupus is a prototypic autoimmune disease with highly heterogeneous manifestations and variable disease activity in which no two cases are alike. Differences can be caused by genetics and epigenetics, pathogenetic mechanisms, demographics, ethnicity and race, as well as socioeconomic factors, and disease heterogeneity can cause challenges with development and selection of therapeutics, perfection of clinical trial designs, and prognostication.
The first episode of this CMEOCast podcast serie... |
|
|
Comprehensive and Coordinated Patient-Centered Care in Psoriatic Arthritis
Understanding patient preferences, values, and needs is essential to patient satisfaction and patient-centered care. Whether via telehealth or in-office treatment, today’s patients and their families want to be engaged in their care. This involves inclusion in personalized decision-making, education about their disease and treatment options, updates on care progress, and arriving at treatment decisions together.
The final episode of this CMEOCast podcast series on psoriatic arthritis (PsA... |
|
|
Adding Tools to the Toolbox: New and Emerging Treatments for Psoriatic Arthritis
The principles of psoriatic arthritis (PsA) treatment include reducing pain, improving quality of life, preventing structural damage and complications, engaging patients in shared decision-making, and identifying comorbidities that may impact treatment decisions. This requires management by a multidisciplinary team. Novel agents and treatment targets have demonstrated efficacy in PsA. Education is needed to ensure that the most up-to-date evidence informs treatment decision-making to optimize ... |
|
|
Eliminating Diagnostic Delays in Psoriatic Arthritis
Psoriatic arthritis (PsA) is a progressive, erosive, chronic, heterogeneous, systemic inflammatory disease affecting six different clinical domains and presents in up to 30% of patients with psoriasis (PsO). Beyond issues caused with joints and skin, PsA can also lead to fatigue, poor sleep quality, diminished work capacity, physical function limitations, and decreased social participation. Early detection and treatment are critical for improving long-term patient outcomes and minimizing irrev... |
|
|
Evidence-Based Strategies to Improve Access to Therapies for Patients with Spinal Muscular Atrophy
Spinal muscular atrophy (SMA) is both a rare disease and the most common fatal genetic disease of infancy. The approval of the first disease-modifying therapy (DMT) for SMA in 2016 revolutionized management, and treatment options have expanded with two additional DMTs approved more recently. However, because SMA is a rare disease, many clinicians and payers have limited knowledge of SMA and the available DMTs, which can contribute to delays in diagnosis and treatment initiation. Evidence-based... |
|
|
Unique Approaches to the Management of Underserved Patients with IBD
There are many disparities in irritable bowel disease (IBD) care, with an incidence rate of IBD hospitalization that is 4x higher in patients with low socio-economic status and a 3x increased ratio of IBD hospitalizations and mortality in Blacks compared to Whites and Hispanics.
The final episode of this CMEOCast podcast series summarizes the discussion points on the racial/ethnic and economic inequality in IBD and offers approaches to mitigate disparities on the level of both individual he... |
|
|
The Role of Socioeconomic Factors in Health Care Delivery in IBD
Certain patients with IBD are more likely to see poor outcomes due to low socioeconomic status (SES). Recognizing and acting on these differences is especially important during the COVID-19 pandemic, the economic consequences of which have disproportionately affected those with low SES.
In the second episode of this CMEOCast podcast series, expert faculty focus on the role of SES and gender bias in the treatment of IBD and offer approaches to mitigating these disparities.
- Learning Obje... |
|
|
The Role of Race in Health Care Delivery in IBD
Although IBD is more common in non-Hispanic Whites compared to other racial groups, there is a disproportionately higher ratio of hospitalizations, surgery, and IBD-related mortality among non-Hispanic African Americans compared with other racial groups. This fact, in addition to the rising prevalence of IBD in North America and the estimate that 54% of the U.S. population will be comprised of minority populations by 2050, underscores the need for high-quality treatment available to racial and... |
|
|
Coronavirus Disease 2019 (COVID-19) and Inflammatory Bowel Disease
The COVID-19 pandemic created many challenges and uncertainty in our healthcare system. One component facing clinicians managing patients with inflammatory bowel disease (IBD) is whether or not to continue providing certain pharmacotherapies in patients who are at increased risk of infection because they are immunocompromised. The consensus of gastroenterologists is that decisions should be made on a case-by-case basis, but that overall, uncontrolled disease activity and inflammation present m... |
|
|
Long-Term Management of HBV: Meeting the Culturally Diverse Needs of Your Patient Community
Despite the high prevalence of hepatitis B virus (HBV) in the United States, only 32% of patients are aware of their HBV status and less than 30% receive treatment. There are six groups who are at especially high risk: foreign-born Asian/Pacific Islanders, Africa-born Black populations, incarcerated persons, people who inject drugs, men who have sex with men, and refugees. Disease awareness is especially low in many of these populations. In conjunction, the disease burden is compounded by cult... |
|
|
Public Health Opportunities in the ED: Step 1: Screen for HBV, Step 2: Link to Care
Screening for hepatitis B virus (HBV) in the emergency department (ED) is an important public health opportunity, as it can reduce transmission in high-risk patients and facilitate linkage to care. HBV testing can be included when screening for sexually transmitted infections (STIs) and hepatitis C virus (HCV), and emergency department (ED) physicians to employ strategies for follow-up, including treatment or vaccination, after receiving HBV results.
The third episode of this CMEOCast podca... |
|
|
HBV Treatment Decision-Making
Chronic hepatitis B virus (HBV) is a serious public health concern that is often underrated despite the approval of newer therapies and subsequent updated guidelines. Integrating guideline-directed treatment can reduce the morbidity and mortality associated with HBV.
In this second episode of the four-part CMEOCast Podcast to Practice series "Meeting Patients Where They Live: Community-Based Efforts to Improve Screening and Treatment of HBV," faculty experts will discuss the efficacy and sa... |
|
|
The HBV Refresher: Screen, Diagnose, Treat
Despite updated guidance from the American Association for the Study of Liver Diseases (AASLD) on the prevention, diagnosis, and treatment of chronic hepatitis B virus (HBV), early detection and implementation of effective treatment remains a challenge.
The first episode of this CMEOcast series on community-based efforts to improve screening and treatment of HBV will guide primary care clinicians through optimal strategies to screen for HBV in at-risk patients and utilize serological test r... |
|
|
Differentiators When Choosing Novel Treatment Options for EDS
Reducing excessive daytime sleepiness (EDS) is an important treatment goal for patients with narcolepsy or obstructive sleep apnea (OSA). In order to achieve reduced EDS, cataplexy and sleep paralysis/hypnagogic hallucinations must be controlled to improve disturbed nighttime sleep, which then improves fatigue and brain fog and reduces psychosocial dysfunction, therefore improving quality of life (QoL). The latest efficacy and safety data should be reviewed, and considerations for treatment se... |
|
|
Matching Treatment Choice to the Pathophysiology of Sleep
The neurobiology of excessive daytime sleepiness (EDS) in obstructive sleep apnea (OSA) has no identified pathophysiology. This can make it difficult for clinicians to determine a target for therapeutic intervention; therefore, awareness of the mechanisms of action of current and novel therapies is vital when selecting an optimal treatment.
In the second episode of this CME Outfitters podcast series on EDS, expert faculty will focus on identifying key neurotransmitters involved in the sleep... |
|
|
Implementing a Shingles Protocol in Pharmacies
Shingles, or herpes zoster, is a common secondary infection that can impose a significant burden, impacting cerebrovascular, cardiovascular, neurologic, ophthalmic, and dermatologic systems. Therefore, despite common perceptions, shingles is more than just a rash, and its extensive burden highlights the need for an effective prevention strategy. While highly effective vaccines exist, shingles vaccination remains low. Community pharmacists play a critical role in educating at-risk patients abou... |
|
|
COVID-19 and Rheumatology Care: How Does it Impact My Patients?
Already facing unprecedented changes in approaches to patient care, rheumatology practices must now navigate the unfamiliar landscape of COVID-19 and translate rapidly evolving evidence into routine clinical practice. And while every day brings new data and guidance on best practices for managing rheumatology patients during a pandemic, it is often the perspectives of our colleagues in the field that provide the dimension and context needed to interpret the latest data and guidance.
This C... |
|
|
Best Practices for Incorporating LAIs into Treatment Planning for Schizophrenia
Schizophrenia is an all-too-often chronic, debilitating disorder that impedes quality of life and psychosocial functioning. Implementation of effective therapy that promotes sustained recovery often poses a challenge for both clinicians and patients. Long-acting injectables (LAIs) can play a critical role in relapse prevention and rehospitalization, and subsequently, recovery and restoration of function.
This CME Outfitters BriefCase will guide clinicians through best practices to identify ... |
|
|
From Bench to Bedside: Applying Clinical Updates to Schizophrenia Management
Per APA Guidelines, treatment goals for schizophrenia include avoiding relapses and exacerbations that can cause immense negative impact on quality of life (QoL). Long-acting injectables (LAIs) are an effective tool for achieving these goals in both acute and chronic phases of illness; however, there is often reluctance to implement their use. A better understanding of the safety and efficacy of LAIs, particularly in comparison to their oral counterparts, can improve treatment decisions for in... |
|
|
Joining Forces in the Coordination of Care of Patients with Psoriatic Arthritis
Delays in diagnosing psoriatic arthritis (PsA) are common, with the median lag time from disease onset to a confirmatory diagnosis being 2.5 years. It is imperative that clinicians recognize the impact of delays in diagnosis on joint damage and patient quality of life, and that a multidisciplinary approach can help with earlier diagnosis and better management of PsA and its comorbidities.
The final installment of this CME Outfitters Snack series on managing PsA features discussion on the in... |
|
|
Mechanistic Rationales for Novel and Emerging Treatments for Psoriatic Arthritis: Plugging the Data into the Equation
Psoriatic arthritis (PsA) can have serious debilitating effects on peripheral joints, the spine, tendon insertions, and fingers. Management of PsA has improved with therapies such as nonpharmacologic and symptomatic treatments, oral small molecules, tumor necrosis factor inhibitors, interleukin (IL)-12/23 inhibitors, IL-17 inhibitors, CTLA4-lg, Janus kinase (JAK)/TyK2 inhibitors, and IL-23 inhibitors; however, complete disease control has not yet been achieved.
This CME Outfitters Snack foc... |
|
|
Pathogenesis of Psoriatic Arthritis: A Broader Understanding to Inform Next Steps
Psoriatic arthritis (PsA) presents in up to 30% of patients with psoriasis (PsO) and may precede, occur concurrently with, or occur after the development of PsO. It is imperative to recognize that PsA can present in the dermatology or rheumatology clinic depending on the primary symptom and that clinicians then accurately diagnose PsA by utilizing screening questionnaires, as well as screening patients with PsA for common comorbidities.
The first episode of this CME Outfitters Snack series ... |
|
|
Adapting and Adjusting: Best Practices for Utilizing Telehealth in Osteoarthritis Management
Osteoarthritis (OA) is the most common form of arthritis, affecting 1 in 3 people over the age of 65. It is the third most rapidly rising cause of disability and the most common reason for decrease in ambulation. With the onset of the COVID-19 pandemic, the US Surgeon General has recommended cancelling elective surgeries, causing a large impact on patients with OA. A survey of 360 patients at 6 surgical centers who had to cancel their hip or knee surgery revealed that 30% would have surgery de... |
|
|
Adopting a Tailored Approach to Managing Unmet Needs in Osteoarthritis
Previously, osteoarthritis (OA) was thought to be a disease of chronic overload and impaired biomechanics on the joint that lead to the destruction of the joint's article cartilage, resulting in inflammation. However, evolving theories link OA to complex inflammatory and metabolic factors, and inadequate pain relief with current treatments is a common aspect of OA treatment which is responsible for a plethora of health care visits and dollars. Additionally, there are concerns about the risks o... |
|
|
Finding Function: A Holistic Approach to Managing Osteoarthritis
There are several different approaches to treating osteoarthritis (OA), including physical, psychosocial, and mind-body. It is important that primary care physicians work in concert with rheumatologists, physical/occupational therapists, psychologists, and dietitians to create a multidisciplinary management plan for their patients with OA, as well as participating in shared decision-making.
In this installment of the CME Outfitters Snack series on managing osteoarthritis, expert faculty dis... |
|
|
Seeing Osteoarthritis Management Through a New Mechanistic Lens
Inadequate pain relief despite current treatments is one of the most troubling aspects of osteoarthritis (OA), and is responsible for the majority of health care visits in patients with OA. Additional concerns about the risks of long-term NSAID and opiate use contribute to unmet treatment needs. It is therefore necessary for clinicians to recognize the role of novel targets for pain management, particularly nerve growth factor, and to evaluate the efficacy and safety of novel mechanisms of act... |
|
|
Weighing the Heavy Burden of Osteoarthritis: Improving Function and Quality of Life
The burden of osteoarthritis (OA) is a heavy one, often leading to poor quality of life (QoL) due to functional limitations and loss of independence, poor sleep quality, fatigue, depressed mood, and increased healthcare expenditures. Additionally, comorbidities such as stroke, peptic ulcer, and metabolic syndrome must be considered. Therefore, proper assessment of a patient's OA, the pain it causes, and the proper utilization of tools such as GAD-7 and PHQ-9 to assess anxiety and depression, a... |
|
|
Signals of Change in the Management of Atopic Dermatitis
Atopic dermatitis (AD) is a chronic, inflammatory skin disease that effects up to 18% of children and up to 10% of adults and can have a substantial negative impact on the quality of life (QoL) of patients and their families. Its management is challenging at any age, with patients and caregivers often becoming overwhelmed by the chronic and relapsing nature of AD. Establishing disease severity is essential to inform treatment decisions, as is information on new clinical trial data for therapie... |
|
|
Unlocking the Value of Biosimilar Therapies in IBD
Over the years, biologic agents have proven their importance in the management of chronic autoimmune diseases including inflammatory bowel disease (IBD). Biosimilars are molecules highly similar to approved biologic medicines that have been developed to mitigate the high costs of biologics. Despite the fact that these therapies are tested to ensure non-inferiority to originator products, questions about appropriate use of biosiilars in IBD remain among clinicians and patients alike.
In this... |
|
|
Rethinking Routines in Multiple Sclerosis Management: What the Future Holds for DMTs and Cognitive Assessment Strategies
Multiple sclerosis (MS) is a chronic inflammatory and neurological disease that is the leading cause of disability in young and middle-aged people in the United States. The number of disease-modifying therapies (DMTs) available for treatment of MS has expanded in recent years, and it is imperative that neurologists and other health care professionals (HCPs) have up-to-date knowledge of clinical efficacy and safety of these therapeutic agents to inform individualized treatment decisions.
Cog... |
|
|
Career Advancement and Leadership Skills for Women in Healthcare - LIVE STREAM
Strategies and Skills Development for Career Advancement and Leadership
Career Advancement and Leadership Skills for Women in Healthcare will be held online this year, using live streaming, electronic Q&A, and other remote learning technologies.
This Harvard Medical School professional development program, which sells out every year, delivers evidence-based strategies, skills development and education that help women at various stages of their healthcare careers step into and succeed in lead... |
|
|
Diagnosis, Treatment and Prevention Therapies in Primary Headache Disorders
Primary headache disorders are a major cause of disability and a common reason people seek medical care. However, distinguishing a primary from a secondary headache disorder, as well as among primary headache disorders, is often challenging. Focusing on cluster and migraine, Drs. Jessica Ailani and Stewart Tepper provide criteria and strategies to overcome this challenge in the office setting. Insight is also provided to help guide treatment with evidence-based medications and devices, includi... |
|